Patents by Inventor Nicholas Doerr

Nicholas Doerr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides inhibiting gamma-c-cytokine activity and methods of use
    Patent number: 12600757
    Abstract: Disclosed herein are stable peptide antagonists based on the consensus yc-subunit binding site to inhibit the activity of yc-cytokines. Such peptide antagonists are capable of inhibiting the activity of multiple yc-cytokine family members. The yc-family cytokines are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (GvHD). Thus, inhibitors of yc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: April 14, 2026
    Assignee: Bioniz Therapeutics, Inc.
    Inventors: Nicholas Doerr, Laith Q. Al-Mawsawi, Nazli Azimi
  • STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY
    Publication number: 20210324029
    Abstract: Disclosed herein are stable peptide antagonists based on the consensus yc-subunit binding site to inhibit the activity of yc-cytokines. Such peptide antagonists are capable of inhibiting the activity of multiple yc-cytokine family members. The yc-family cytokines are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (GvHD). Thus, inhibitors of yc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
    Type: Application
    Filed: April 4, 2018
    Publication date: October 21, 2021
    Inventors: Nicholas Doerr, Laith Q. Al-Mawsawi, Nazli Azimi